GRDN
Guardian Pharmacy Services, Inc. NYSE Listed Apr 21, 2016$44.99
-0.13%
vs $45.05
Mkt Cap $2.8B
52w Low $23.14
86.7% of range
52w High $48.33
50d MA $40.43
200d MA $36.43
P/E (TTM)
43.2x
EV/EBITDA
24.4x
P/B
12.9x
Debt/Equity
0.2x
ROE
23.8%
P/FCF
35.3x
RSI (14)
77.70
ATR (14)
$2.01
Beta
0.47
50d MA
$40.43
200d MA
$36.43
Avg Volume
596.4K
Guardian Pharmacy Services, Inc., a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes. The company's Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, track, and optimize their business operations; and GuardianShield Programs for LTCFs. The company was founded in 2003 and is based in Atlanta, Georgia.
300 Galleria Parkway SE · Atlanta, GA 30339 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 6, 2026 | AMC | 0.26 | 0.29 | +10.8% | 39.47 | +9.3% | +11.0% | -5.4% | -4.8% | -2.2% | -0.3% | — |
| May 6, 2026 | AMC | 0.24 | 0.29 | +20.8% | 36.58 | -3.4% | -0.8% | -0.5% | -1.2% | -2.1% | +2.2% | — |
| Mar 11, 2026 | AMC | 0.27 | 0.37 | +37.0% | 33.51 | +3.0% | -0.7% | -2.0% | +1.0% | +3.5% | -0.5% | — |
| Nov 10, 2025 | AMC | 0.24 | 0.25 | +4.2% | 29.75 | +7.3% | +5.0% | +1.0% | -3.6% | -4.0% | -3.0% | — |
| Aug 11, 2025 | AMC | 0.22 | 0.23 | +4.5% | 19.88 | +3.1% | +13.8% | +4.1% | +1.4% | -1.1% | +5.1% | — |
| May 12, 2025 | AMC | 0.22 | 0.21 | -4.5% | 25.66 | -1.0% | -4.0% | -2.1% | +3.3% | -0.9% | +7.4% | — |
| Mar 26, 2025 | AMC | 0.21 | 0.24 | +14.3% | 20.23 | -3.6% | +4.3% | -4.5% | +5.5% | -1.2% | +2.5% | — |
| Nov 12, 2024 | AMC | 0.19 | -2.00 | -1152.6% | 22.18 | -12.8% | -10.7% | +6.1% | -0.3% | +2.2% | +0.8% | — |
| Sep 26, 2024 | AMC | — | 0.17 | — | 16.00 | +3.1% | +10.9% | -5.4% | +2.9% | +0.5% | -2.4% | — |
| Aug 22, 2024 | AMC | — | 0.24 | — | — | — | — | — | — | — | — | — |
| Dec 31, 2023 | AMC | — | 0.10 | — | — | — | — | — | — | — | — | — |
| Sep 30, 2023 | AMC | — | -0.19 | — | — | — | — | — | — | — | — | — |
| Jun 30, 2023 | AMC | — | 0.35 | — | — | — | — | — | — | — | — | — |
| Mar 31, 2023 | AMC | — | 0.03 | — | — | — | — | — | — | — | — | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 27 | BofA Securities | Initiates | Buy | $42 | $37.57 | $38.15 | +1.5% | +1.0% | -0.9% | -0.1% | -1.3% | +0.7% |
| Apr 13 | Truist | Maintains | Buy → Buy | — | $39.15 | $39.13 | -0.1% | +0.9% | -4.3% | -1.9% | -0.4% | +1.6% |
| Mar 12 | Oppenheimer | Maintains | Outperform → Outperform | — | $33.51 | $34.52 | +3.0% | -0.7% | -2.0% | +1.0% | +3.5% | -0.5% |
| Mar 12 | Truist | Maintains | Buy → Buy | — | $33.51 | $34.52 | +3.0% | -0.7% | -2.0% | +1.0% | +3.5% | -0.5% |
| Jan 14 | Stephens & Co. | Maintains | Overweight → Overweight | — | $31.26 | $31.81 | +1.8% | -3.6% | -2.1% | -8.4% | +4.8% | +3.6% |
| Nov 14 | Truist | Maintains | Buy → Buy | — | $30.42 | $30.52 | +0.3% | -4.0% | -3.0% | -1.5% | -1.3% | +0.3% |
| Sep 26 | Truist | Maintains | Buy → Buy | — | $25.45 | $25.60 | +0.6% | +2.2% | +0.2% | +0.6% | -7.2% | +0.3% |
| May 19 | Truist | Maintains | Buy → Buy | — | $24.69 | $24.79 | +0.4% | +7.4% | -0.1% | -16.8% | +2.4% | -2.8% |
| Apr 11 | Truist | Maintains | Buy → Buy | — | $21.76 | $22.07 | +1.4% | +5.1% | +0.1% | +1.9% | +0.9% | +2.5% |
| Nov 15 | Truist | Maintains | Buy → Buy | — | $21.00 | $21.17 | +0.8% | -0.3% | +2.2% | +0.8% | -1.3% | +3.8% |
No insider trades available.
8-K · 1.01
!! High
Guardian Pharmacy Services, Inc. -- 8-K 1.01: Material Agreement
Guardian Pharmacy Services amended a material agreement, with full details available in the attached exhibit, though the specific terms and financial impact remain unclear from this disclosure alone.
May 28
8-K
Unknown — 8-K Filing
Garden Inc. has secured investor commitments through stock purchase agreements expiring June 30, 2026 or 180 days after a public offering, providing near-term capital flexibility but potential dilution depending on exercise timing.
Mar 23
8-K
Unknown — 8-K Filing
Guardian Pharmacy Services raised 2026 EBITDA guidance, signaling management confidence in operational improvements and sustained growth that should support stock appreciation.
Mar 11
Institutional (13F) — Top 20
All ↗
| # | Manager | Shares | Value | Chg | Period |
|---|---|---|---|---|---|
| 1 | Fmr Llc | 2,359,357 | $89M | Added | Mar 2026 |
| 2 | Blackrock, Inc. | 1,575,989 | $66M | New | Jun 2026 |
| 3 | Vanguard Capital Management Llc | 1,379,750 | $58M | Added | Jun 2026 |
| 4 | Woodline Partners Lp | 1,306,318 | $49M | Added | Mar 2026 |
| 5 | Valiant Capital Management, L.p. | 1,186,658 | $45M | Reduced | Mar 2026 |
| 6 | Boston Partners | 983,868 | $41M | Reduced | Jun 2026 |
| 7 | Timessquare Capital Management, Llc | 951,637 | $40M | New | Jun 2026 |
| 8 | Franklin Resources Inc | 952,952 | $36M | Reduced | Mar 2026 |
| 9 | Jennison Associates Llc | 626,664 | $26M | Added | Jun 2026 |
| 10 | Marshall Wace, Llp | 417,710 | $16M | New | Mar 2026 |
| 11 | Braun Stacey Associates Inc | 339,947 | $14M | New | Jun 2026 |
| 12 | Vanguard Portfolio Management Llc | 258,239 | $11M | Added | Jun 2026 |
| 13 | Alyeska Investment Group, L.p. | 275,000 | $10M | New | Mar 2026 |
| 14 | Sei Investments Co | 246,285 | $10M | Reduced | Jun 2026 |
| 15 | Riverbridge Partners Llc | 244,585 | $10M | New | Jun 2026 |
| 16 | Raymond James Financial Inc | 261,019 | $10M | New | Mar 2026 |
| 17 | Nuveen, Llc | 220,791 | $9M | Reduced | Jun 2026 |
| 18 | Morgan Stanley | 292,502 | $9M | Reduced | Dec 2025 |
| 19 | Peregrine Capital Management Llc | 185,383 | $8M | Reduced | Jun 2026 |
| 20 | Clearbridge Investments, Llc | 202,815 | $8M | Reduced | Mar 2026 |
Mutual Funds / ETFs (N-PORT) — Top 20
All ↗
Valuation
Market Cap
$2.85B
Enterprise Value
$2.78B
P/E (TTM)
43.22x
Forward P/E
36.76x
PEG Ratio
-0.26x
P/B
12.88x
P/S
1.95x
P/FCF
35.28x
EV/EBITDA
24.40x
Shares Out
63.3M
Financials (TTM)
Revenue
$1.46B
Net Income
$65.9M
EBITDA
$114.0M
Free Cash Flow
$80.7M
Op Cash Flow
$100.3M
EPS Basic
$0.79
EPS Diluted
$1.03
EPS Forward
$1.22
Gross Margin
21.6%
Op Margin
6.3%
Net Margin
4.5%
Balance Sheet
Total Assets
$412.7M
Total Liab.
$194.7M
Total Equity
$217.9M
Cash
$65.6M
LT Debt
$0
Book Value/Sh
$3.49
Debt/Equity
0.22x
Current Ratio
1.38
Quick Ratio
1.11
Returns & Growth
ROE
23.8%
ROA
11.9%
ROIC
22.3%
Rev Growth YoY
+17.9%
EPS Growth YoY
+144.6%
Price Returns
2W
+12.1%
1M
+18.5%
3M
+7.4%
6M
+30.8%
12M
+76.9%
Technicals
52W High
$48.33
52W Low
$23.14
50d MA
$40.43
200d MA
$36.43
RSI (14)
77.70
ATR (14)
$2.01
Beta
0.47
Avg Volume
596K
Dividends
Div Rate
$0.00
Div Yield
—
Frequency
—
Ex-Div Date
—
Analyst Price Targets
Consensus
$38.00
High
$40.00
Low
$36.00
Median
$38.00
Data updated apr 25, 2026 12:16pm
· Source: financialmodelingprep.com